BIO-TECHNE Corp
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
TECH$72.83+0.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets
(in thousands, except share and per share data)
| | | | | | | |
|---|---|---|---|---|---|---|
| · September 30, · · · | ||||||
| · · 2025 · · June 30, | ||||||
| · · (unaudited) · · 2025 | ||||||
| ASSETS · · | ||||||
| Current assets: · · | ||||||
| Cash and cash equivalents | | $144,962 | | $162,186 | ||
| Accounts receivable, less allowances of $4,375 and $4,215, respectively | | 183,897 | | 206,876 | ||
| Inventories | | 203,188 | | 189,446 | ||
| Current assets held-for-sale | | | — | | | 12,332 |
| Other current assets | | | 77,460 | | 37,460 | |
| Total current assets | | 609,507 | | 608,300 | ||
| | | | | | | |
| Property and equipment, net | | 240,334 | | 245,719 | ||
| Right-of-use assets | | 70,725 | | 73,399 | ||
| Goodwill | | 978,912 | | 980,935 | ||
| Intangible assets, net | | 350,107 | | 365,599 | ||
| Other assets | | 276,563 | | 283,916 | ||
| Total assets | | $2,526,148 | | $2,557,868 | ||
| LIABILITIES AND SHAREHOLDERS’ EQUITY | | | ||||
| Current liabilities: | | | ||||
| Trade accounts payable | | $30,157 | | $25,311 | ||
| Salaries, wages and related accruals | | 43,599 | | 65,791 | ||
| Accrued expenses | | 19,179 | | 25,663 | ||
| Contract liabilities | | 30,445 | | 32,571 | ||
| Income taxes payable | | 2,848 | | 10,770 | ||
| Operating lease liabilities - current | | 13,771 | | 14,098 | ||
| Other current liabilities | | 4,546 | | 1,645 | ||
| Total current liabilities | | 144,545 | | 175,849 | ||
| | | | | | | |
| Deferred income taxes | | 11,273 | | 6,169 | ||
| Long-term debt obligations | | 300,000 | | 346,000 | ||
| Operating lease liabilities | | 80,702 | | 83,960 | ||
| Other long-term liabilities | | 23,814 | | 27,082 | ||
| | | | ||||
| Shareholders’ equity: | | | | | | |
| Undesignated capital stock, no par; authorized 5,000,000 shares; none issued or outstanding | | — | | — | ||
| Common stock, par value $.01 per share; authorized 400,000,000; issued and outstanding 155,749,477 and 154,972,196 respectively | | 1,557 | | 1,550 | ||
| Additional paid-in capital | | 946,118 | | 911,089 | ||
| Retained earnings | | 1,082,534 | | 1,066,049 | ||
| Accumulated other comprehensive loss | | (64,395) | | (59,880) | ||
| Total shareholders’ equity | | 1,965,814 | | 1,918,808 | ||
| Total liabilities and shareholders’ equity | | $2,526,148 | | $2,557,868 | ||
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.